semaglutide and blindness provides powerful protection against diabetic retinopathy, the leading cause of in working-age adults, Greek study suggests Ozempic may be linked to

These changes include reduced hunger frequency, earlier satiety, smaller portion sizes, and decreased frequency of eating occasions

A number of companies maintain they are allowed to sell compounded glucagon-like peptide 1 receptor agonists (GLP-1RAs), which are considerably cheaper than branded versions, at a personalised dose

SCFAs have also been shown to stimulate the production of tight junction proteins, resulting in increased blood-brain barrier integrity [9]

Specific populations carry meaningful risk and should avoid intermittent fasting while on GLP-1 medications without close medical supervision

These include bleeding, infections, heart problems, and a longer hospital stay